Search Results
Harnessing Genetics to Identify Druggable Targets and Causes of Off-Target Cardiotoxicity
Accurate Prediction of On- and Off-target Cardiotoxicity with Human iPSC-Derived Cardiomyocytes
Investigative in vitro Drug Toxicology with Human iPSC derived Cardiomyocytes
Tragante et al; Druggability of CAD Risk Loci
Keynote Lecturer Christine Seidman on Genetic Approaches to Cardiomyopathy
Illuminating the Druggable Genome: Cure or no Cure?
Webinar: Using Human Cardiomyocytes in Phenotypic Screens and Target Verification
WEBINAR: Exploring the Role of iPSC-Cardiomyocytes in Drug Discovery and Safety Assessment
Broad Paper Vids: Study of both common and rare variation yields insight into cardiac arrhythmia
Gene Editing: Overhyped or Unstoppable Tide?
Stem Cell and Gene Therapy for CV Disease: Lessons learned and future directions
Judith Campisi - Senolytic drugs: Finding the right target(s)
